HIV Citation List: March 4, 2011- March 17, 2011

Pubmed citations:

1. HIV-1 IN Strand Transfer Chelating Inhibitors: A Focus on Metal Binding. Bacchi, A., M. Carcelli, C. Compari, E. Fisicaro, N. Pala, G. Rispoli, D. Rogolino, T.W. Sanchez, M. Sechi, and N. Neamati. Molecular Pharmacology, 2011. [Epub ahead of print]; PMID[21323359].

[Pubmed]. HIV_0304-031711.

2. Antiviral activity of seed extract from Citrus bergamia towards human retroviruses. Balestrieri, E., F. Pizzimenti, A. Ferlazzo, S.V. Giofre, D. Iannazzo, A. Piperno, R. Romeo, M.A. Chiacchio, A. Mastino, and B. Macchi. Bioorganic & Medicinal Chemistry, 2011. 19(6): p. 2084-2089; PMID[21334901].

[Pubmed]. HIV_0304-031711.

3. Magnesium Chelating 2-Hydroxyisoquinoline-1,3(2H,4H)-diones, as Inhibitors of HIV-1 Integrase and/or the HIV-1 Reverse Transcriptase Ribonuclease H Domain: Discovery of a Novel Selective Inhibitor of the Ribonuclease H Function. Billamboz, M., F. Bailly, C. Lion, N. Touati, H. Vezin, C. Calmels, M.L. Andreola, F. Christ, Z. Debyser, and P. Cotelle. Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21366258].

[Pubmed]. HIV_0304-031711.

4. A Novel Anti-HIV Macrocyclic Peptide from Palicourea c ondensata. Bokesch, H.R., L.K. Pannell, P.K. Cochran, R.C. Sowder II, T.C. McKee, and M.R. Boyd. Journal of Natural Products, 2001. 64(2): p. 249-250; PMID[11430013].

[Pubmed]. HIV_0304-031711.

5. Synthesis and HIV-1 integrase inhibition of novel bis-or tetra-coumarin analogues. Chiang, C.C., J.F. Mouscadet, H.J. Tsai, C.T. Liu, and L.Y. Hsu. Chemical & Pharmaceutical Bulletin, 2007. 55(12): p. 1740-1743; PMID[18057750].

[Pubmed]. HIV_0304-031711.

6. From beta-Amino-gamma-sultone to Unusual Bicyclic Pyridine and Pyrazine Heterocyclic Systems: Synthesis and Cytostatic and Antiviral Activities. de Castro, S., O. Familiar, G. Andrei, R. Snoeck, J. Balzarini, M.J. Camarasa, and S. Velazquez. ChemMedChem, 2011. [Epub ahead of print]; PMID[21370477].

[Pubmed]. HIV_0304-031711.

7. Agonist-induced internalization of CCR5 as a mechanism to inhibit HIV replication. Ferain, T., H.R. Hoveyda, F. Ooms, D. Schols, J. Bernard, and G. Fraser. Journal of Pharmacology and Experimental Therapeutics, 2011. [Epub ahead of print]; PMID[21389095].

[Pubmed]. HIV_0304-031711.

8. Study of the inhibition capacity of an 18-mer peptide domain of GBV-C virus on gp41-FP HIV-1 activity. Haro, I., M.J. Gomara, R. Galatola, O. Domenech, J. Prat, V. Girona, and M.A. Busquets. Biochimica et Biophysica Acta, 2011. [Epub ahead of print]; PMID[21377446].

[Pubmed]. HIV_0304-031711.

9. Indolylarylsulfones as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: New Cyclic Substituents at Indole-2-carboxamide. La Regina, G., A. Coluccia, A. Brancale, F. Piscitelli, V. Gatti, G. Maga, A. Samuele, C. Pannecouque, D. Schols, J. Balzarini, E. Novellino, and R. Silvestri. Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21366296].

[Pubmed]. HIV_0304-031711.

10. S/GSK1349572, a new integrase inhibitor for the treatment of HIV: promises and challenges. Lenz, J.C. and J.K. Rockstroh. Expert Opinion on Investigational Drugs, 2011. 20(4): p. 537-548; PMID[21381981].

[Pubmed]. HIV_0304-031711.

11. Novel potent pyrimido[4,5-c], Pubmed, HIV_0304-031811quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties. Pierre, F., S.E. O'Brien, M. Haddach, P. Bourbon, M.K. Schwaebe, E. Stefan, L. Darjania, R. Stansfield, C. Ho, A. Siddiqui-Jain, N. Streiner, W.G. Rice, K. Anderes, and D.M. Ryckman. Bioorganic & Medicinal Chemistry Letters, 2011. 21(6): p. 1687-1691; PMID[21316963].

[Pubmed]. HIV_0304-031711.

12. RNA-Binding and Viral Reverse Transcriptase Inhibitory Activity of a Novel Cationic Diamino Acid-Based Peptide. Roviello, G.N., S. Di Gaetano, D. Capasso, S. Franco, C. Crescenzo, E.M. Bucci, and C. Pedone. Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21391685].

[Pubmed]. HIV_0304-031711.

13. Anti-HIV activity of Indian medicinal plants. Sabde, S., H.S. Bodiwala, A. Karmase, P.J. Deshpande, A. Kaur, N. Ahmed, S.K. Chauthe, K.G. Brahmbhatt, R.U. Phadke, D. Mitra, K.K. Bhutani, and I.P. Singh. Journal of Natural Medicines, 2011. [Epub ahead of print]; PMID[21365365].

[Pubmed]. HIV_0304-031711.

14. Mechanism of resistance to GS-9148 by the Q151L mutation in HIV-1 Reverse Transcriptase. Scarth, B.J., K.L. White, J.M. Chen, E.B. Lansdon, S. Swaminathan, M.D. Miller, and M. Gotte. Antimicrob Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21402840].

[Pubmed]. HIV_0304-031711.

15. Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors. Sharma, H., S. Patil, T.W. Sanchez, N. Neamati, R.F. Schinazi, and J.K. Buolamwini. Bioorganic & Medicinal Chemistry, 2011. 19(6): p. 2030-2045; PMID[21371895].

[Pubmed]. HIV_0304-031711.

16. 3-Hydroxypyrimidine-2,4-diones as an Inhibitor Scaffold of HIV Integrase. Tang, J., K. Maddali, M. Metifiot, Y.Y. Sham, R. Vince, Y. Pommier, and Z. Wang. Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21381765].

[Pubmed]. HIV_0304-031711.

17. Antiviral hyperactivation-limiting therapeutics as a novel class for the treatment of HIV/AIDS: focus on VS411. Uglietti, A. and R. Maserati. Expert Opinion on Investigational Drugs, 2011. 20(4): p. 559-565; PMID[21391888].

[Pubmed]. HIV_0304-031711.

18. Analyses of Anti-HIV-1 Activity of a Small CCR5 Peptide Antagonist. Wang, F., S. He, Z.J. Zhang, L.F. He, X. Chen, and T. Teng. AIDS Research and Human Retroviruses, 2011. [Epub ahead of print]; PMID[21375388].

[Pubmed]. HIV_0304-031711.

ISI Web of Knowledge citations:

19. Dimeric 2G12 as a Potent Protection against HIV-1. Luo, X.M., M.Y.Y. Lei, R.A. Feidi, A.P. West, A.B. Balazs, P.J. Bjorkman, L.L. Yang, and D. Baltimore. PLoS Pathogens, 2010. 6(12); ISI[000285587500013].

[WOS]. HIV_0304-031711.

20. 6-Benzylamino 4-oxo-1,4-dihydro-1,8-naphthyridines and 4-oxo-1,4-dihydroquinolines as HIV integrase inhibitors. Nagasawa, J.Y., J. Song, H.M. Chen, H.W. Kim, J. Blazel, S. Ouk, B. Groschel, V. Borges, V. Ong, L.T. Yeh, J.L. Girardet, J.M. Vernier, A.K. Raney, and A.B. Pinkerton. Bioorganic & Medicinal Chemistry Letters, 2011. 21(2): p. 760-763; ISI[000285998000031]

[WOS]. HIV_0304-031711.

21. Identification of a Novel Scaffold for Allosteric Inhibition of Wild Type and Drug Resistant HIV-1 Reverse Transcriptase by Fragment Library Screening. Geitmann, M., M. Elinder, C. Seeger, P. Brandt, I.J.P. de Esch, and U.H. Danielson. Journal of Medicinal Chemistry, 2011. 54(3): p. 699-708; ISI[000286798100002].

[WOS]. HIV_0304-031711.

22. Deconstruction of Non-Nucleoside Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Type 1 for Exploration of the Optimization Landscape of Fragments. Brandt, P., M. Geitmann, and U.H. Danielson. Journal of Medicinal Chemistry, 2011. 54(3): p. 709-718; ISI[000286798100003].

[WOS]. HIV_0304-031711.

23. Synthesis and Anti-HIV Activity of New 3 '-O-Phosphonylmethyl Nucleosides. Cesnek, M. and P. Herdewijn. Heterocycles, 2010. 82(1): p. 663-687; ISI[000286906100045].

[WOS]. HIV_0304-031711.

24. Triple Hyp -> Pro Replacement in Integramide A, a Peptaib Inhibitor of HIV-1 Integrase: Effect on Conformation and Bioactivity. De Zotti, M., W. De Borggraeve, B. Kaptein, Q.B. Broxterman, S.B. Singh, P.J. Felock, D.J. Hazuda, F. Formaggio, and C. Toniolo. Biopolymers, 2011. 96(1): p. 49-59; ISI[000286957400008].

[WOS]. HIV_0304-031711.

25. Modeling and Spectroscopic Studies of Synthetic Diazabicyclo Analogs of the HIV-1 Inhibitor BMS-378806 and Evaluation of Their Antiviral Activity. Legnani, L., D. Colombo, E. Cocchi, L. Solano, S. Villa, L. Lopalco, V. Asti, L. Diomede, F.M. Albini, and L. Toma. European Journal of Organic Chemistry, 2011(2): p. 287-294; ISI[000286964500011].

[WOS]. HIV_0304-031711.

26. Construction, Expression and Activities of a Novel Anti-HIV-1 Protein GRFT. Li, C., X.A. Li, Y.S. Liu, F. Yu, J.L. Han, B. Hu, M. Ye, J. Wang, S.W. Du, and N.Y. Jin. Chemical Journal of Chinese Universities-Chinese, 2011. 32(1): p. 95-99; ISI[000287008700019].

[WOS]. HIV_0304-031711.

27. A Quantitative Structure-Activity Relationship Studies On a Series of 4,1-Benzoxazepinone Analogues of Efavirenz, as HIV-1 Reverese Transcriptase Inhibitors. Srivastava, P.L. and N. Kesharwani. Oxidation Communications, 2010. 33(4): p. 943-947; ISI[000287017000020].

[WOS]. HIV_0304-031711.

28. Water-soluble Phenolic Compounds and Their Anti-HIV-1 Activities from the Leaves of Cyclocarya paliurus. Zhang, J.A., N. Huang, J.C. Lu, X. Li, Y.H. Wang, L.M. Yang, Y.T. Zheng, and K. Xiao. Journal of Food and Drug Analysis, 2010. 18(6): p. 398-404; ISI[000287076500004].

[WOS]. HIV_0304-031711.

29. Modification and biological evaluation of novel 4-hydroxy-pyrone derivatives as non-peptidic HIV-1 protease inhibitors. He, M.Z., N. Yang, C.L. Sun, X.J. Yao, and M. Yang. Medicinal Chemistry Research, 2011. 20(2): p. 200-209; ISI[000287204700009].

[WOS]. HIV_0304-031711.

30. Recombinant expression of Polygonatum cyrtonema lectin with anti-viral, apoptosis-inducing activities and preliminary crystallization. Li, C.Y., P. Luo, J.J. Liu, E.Q. Wang, W.W. Li, Z.H. Ding, L. Mou, and J.K. Bao. Process Biochemistry, 2011. 46(2): p. 533-542; ISI[000287274000016].

[WOS]. HIV_0304-031711.

31. Synthesis and anti-HIV activities of bis-(cycloSaligenyl) pronucleotides derivatives of 3 '-fluoro-3 '-deoxythymidine and 3 '-azido-3 '-deoxythymidine. Ahmadibeni, Y., R. Tiwari, C. Swepson, J. Pandhare, C. Dash, G.F. Doncel, and K. Parang. Tetrahedron Letters, 2011. 52(7): p. 802-805; ISI[000287340700016].

[WOS]. HIV_0304-031711.

32. In vitro antibacterial, antioxidant, total phenolic contents and anti-HIV-1 reverse transcriptase activities of extracts of seven Phyllanthus sp. Eldeen, I.M.S., E.M. Seow, R. Abdullah, and S.F. Sulaiman. South African Journal of Botany, 2011. 77(1): p. 75-79; ISI[000287350800009].

[WOS]. HIV_0304-031711.

33. Synthesis and biological activity of the pinostrobin oxime complex compounds with some d-metals. Mashentseva, A.A., T.S. Seytembetov, S.M. Adekenov, B.I. Tuleuov, O.P. Loiko, and A.I. Khalitova. Russian Journal of General Chemistry, 2011. 81(1): p. 96-101; ISI[000287594400014].

[WOS]. HIV_0304-031711.

34. An antifungal defensin from Phaseolus vulgaris cv. 'Cloud Bean'. Wu, X.L., J.A. Sun, G.Q. Zhang, H.X. Wang, and T.B. Ng. Phytomedicine, 2011. 18(2-3): p. 104-109; ISI[000287767800003].

[WOS]. HIV_0304-031711.